WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
The House Republicans’ budget blueprint, blessed by Speaker Mike Johnson, has long been stalled in the chamber. On Tuesday, Arrington called for a Thursday committee meeting to resolve vast ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...
GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...
Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results